LC
THC icon

Lindbrook Capital’s Tenet Healthcare THC Stock Holding History

Lindbrook Capital’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$192K Buy
1,427
+72
+5% +$9.48K 0.02% 428
2024
Q4 		$171K Sell
1,355
-100
-7% -$14.9K 0.02% 416
2024
Q3 		$242K Buy
1,455
+19
+1% +$2.87K 0.02% 351
2024
Q2 		$191K Buy
1,436
+185
+15% +$22.3K 0.02% 373
2024
Q1 		$131K Buy
1,251
+8
+0.6% +$719 0.01% 463
2023
Q4 		$93.9K Buy
1,243
+1
+0.1% +$63 0.01% 539
2023
Q3 		$81.8K Buy
1,242
+10
+0.8% +$748 0.01% 522
2023
Q2 		$100K Buy
1,232
+10
+0.8% +$712 0.01% 483
2023
Q1 		$72.6K Buy
1,222
+32
+3% +$1.78K 0.01% 570
2022
Q4 		$58.1K Sell
1,190
-101
-8% -$4.67K 0.01% 639
2022
Q3 		$67K Sell
1,291
-265
-17% -$15.7K 0.01% 560
2022
Q2 		$82K Sell
1,556
-94
-6% -$6.54K 0.01% 498
2022
Q1 		$142K Sell
1,650
-137
-8% -$11.3K 0.02% 371
2021
Q4 		$146K Buy
1,787
+767
+75% +$56.1K 0.02% 386
2021
Q3 		$68K Hold
1,020
– – 0.02% 359
2021
Q2 		$68K Hold
1,020
– – 0.02% 384
2021
Q1 		$53K Hold
1,020
– – 0.01% 428
2020
Q4 		$41K Hold
1,020
– – 0.01% 467
2020
Q3 		$25K Hold
1,020
– – 0.01% 549
2020
Q2 		$18K Sell
1,020
-8
-0.8% -$158 0.01% 651
2020
Q1 		$15K Sell
1,028
-110
-10% -$3.16K 0.01% 646
2019
Q4 		$43K Buy
1,138
+110
+11% +$3.29K 0.02% 491
2019
Q3 		$23K Hold
1,028
– – 0.01% 660
2019
Q2 		$21K Hold
1,028
– – 0.01% 687
2019
Q1 		$29K Hold
1,028
– – 0.01% 571
2018
Q4 		$17K Buy
+1,028
New +$24.9K 0.01% 679

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lindbrook Capital's THC Position: Q1 2025 in Review

Lindbrook Capital increased its Tenet Healthcare (THC) stake by 5.3% in Q1 2025, buying an estimated $9.48K and bringing the position to 1,427 shares worth $192K. The position accounts for 0.02% of the portfolio, ranked #428.

Lindbrook Capital first reported a position in THC in Q4 2018 and has held it in 26 quarters since. The position peaked at $242K in Q3 2024. 566 funds tracked by Wall St. Rank hold THC as of Q1 2025.

  • Lindbrook Capital held 1,427 shares of Tenet Healthcare worth $192K as of Q1 2025.
  • Lindbrook Capital bought 72 Tenet Healthcare shares in Q1 2025, an estimated $9.48K.
  • Tenet Healthcare made up 0.02% of Lindbrook Capital's portfolio in Q1 2025, its #428 holding.
  • Lindbrook Capital first reported a position in Tenet Healthcare in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Tenet Healthcare position peaked at $242K in Q3 2024.
  • 566 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.